A-Alpha Bio Welcomes Heidi Hagen to Its Board of Directors

We’re thrilled to announce the appointment of Heidi Hagen to our Board of Directors! With over 30 years of experience as a biotechnology leader, founder, and operator, Heidi is perfectly positioned to thrive in her role as A-Alpha Bio’s first independent board member. Her expertise will be instrumental in the successful development of our platforms, progressing our pipeline, and advancing A-Alpha Bio’s mission to improve human health by measuring and engineering protein-protein interactions. 

Over the course of her career, Heidi has built an extensive track record in leading strategy and operations to progress innovative technologies from ideation to commercialization. Having been a core member of pharma companies like Vineti, Sotio, and Dendreon, she intimately understands how pharma and biotech companies operate and scale from startup to global organization. It is an absolute privilege to have Heidi on board and we are excited for what the future holds! 

You can read more about Heidi’s appointment in our press release here.